Journals / Trakya Üniversitesi Tıp Fakültesi Dergisi / 2009 / Cilt: 26 - Sayı: 2

Atrakuryum, rokuronyum, mivakuryum, sisatrakuryum, pankuronyum ve vekuronyumda Escherichia coli üremesi

Growth of Escherichia coli in atracurium, rocuronium, mivacurium, cisatracurium, pancuronium, and vecuronium

Pages
100–104
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Rocuronium had more powerful antimicrobial effects than the other neuromuscular agents.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We studied in vivo growth of Escherichia coli in atracurium, rocuronium, mivacurium, cisatracurium, pancuronium, and vecuronium.
📊
Key Findings & Data:Patients and Methods: The pathogen was exposed to atracurium, rocuronium, mivacurium, cisatracurium, pancuronium and vecuronium for 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 h at room temperature, respectively.
💡
Conclusion & Impact:Conclusion: Rocuronium had more powerful antimicrobial effects than the other neuromuscular agents.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Pankuroniyum · Vekuronyum bromid · Escherichia coli

Abstract

Objectives: We studied in vivo growth of Escherichia coli in atracurium, rocuronium, mivacurium, cisatracurium, pancuronium, and vecuronium. Patients and Methods: The pathogen was exposed to atracurium, rocuronium, mivacurium, cisatracurium, pancuronium and vecuronium for 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 h at room temperature, respectively. Results: The mean colony counts of Escherichia coli after exposure to rocuronium was significantly lower than the counts after exposure to atracurium, mivacurium, cisatracurium, pancuronium and vecuronium (p=0.002, 0.000, 0.000, 0.001, and 0.002, respectively). No significant difference was found with respect to the mean colony counts with atracurium, mivacurium, cisatracurium, pancuronium and vecuronium (p<0.05). Conclusion: Rocuronium had more powerful antimicrobial effects than the other neuromuscular agents.

Özet

Amaç: Biz çalışmamızda atrakuryum, rokuronyum, mivakuryum, sisatrakuryum, pankuronyum ve vekuronyumun Escherichia coli üremesi üzerine olan etkinliğini araştırdık. Hastalar ve Yöntemler: Patojen bakteri, atrakuryum, rokuronyum, mivakuryum, sisatrakuryum, pankuronyum ve vekuronyum ile 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, ve 24 saat oda sıcaklığında temas ettirildi. Bulgular: Escherichia coli ortalama koloni sayısı rokuronyumda istatiksel anlamlı olarak atrakuryum, mivakuryum, sisatrakuryum, pankuronyum ve vekuronyumdan daha düşük saptandı (sırasıyla p=0.002, 0.000, 0.000, 0.001, ve 0.002). Atrakuryum, mivakuryum, sisatrakuryum, pankuronyum ve vekuronyumda ortalama koloni sayısı açısından anlamlı fark saptanmadı (p<0.05). Sonuç: Rokuronyum, diğer nöromusküler kas gevşetici ajanlardan daha kuvvetli antimikrobiyal etki gösterdi.

🔖

Cite This Article

MEMİŞ, D., OTKUN, M., BAHAR, M., SÜT, N. (2009). Atrakuryum, rokuronyum, mivakuryum, sisatrakuryum, pankuronyum ve vekuronyumda Escherichia coli üremesi. Trakya Üniversitesi Tıp Fakültesi Dergisi, Cilt: 26 - Sayı: 2, 100–104. https://ajindex.com/articles/325822

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Bátai I, Kerényi M, Tekeres M. The impact of drugs used in anaesthesia on bacteria. Eur J Anaesthesiol 1999;16:425-40
  2. Lessard MR, Trépanier CA, Gourdeau M, Denault PH. A microbiological study of the contamination of the syringes used in anaesthesia practice. Can J Anaesth 1988;35:567-9
  3. Morgan GE, Mikhail MS. Muscle relaxants. In: Clinical anesthesiology. 2nd ed. Stamford: Appleton & Lange; 1996. p. 149-64
  4. Graystone S, Wells MF, Farrell DJ. Do intensive care drug infusions support microbial growth? Anaesth Intensive Care 1997;25:640-2
  5. Sato S, Sakuragi T, Dan K. Human skin flora as a potential source of epidural abscess. Anesthesiology 1996;85:1276-82
  6. Sakuragi T, Yanagisawa K, Shirai Y, Dan K. Growth of Escherichia coli in propofol, lidocaine, and mixtures of propofol and lidocaine. Acta Anaesthesiol Scand 1999;43:476-9
  7. Pere P, Lindgren L, Vaara M. Poor antibacterial effect of ropivacaine: comparison with bupivacaine. Anesthesiology 1999;91:884-6
  8. Hodson M, Gajraj R, Scott NB. A comparison of the antibacterial activity of levobupivacaine vs. bupivacaine: an in vitro study with bacteria implicated in epidural infection. Anaesthesia 1999;54:699-702
  9. Aydin ON, Eyigor M, Aydin N. Antimicrobial activity of ropivacaine and other local anaesthetics. Eur J Anaesthesiol 2001;18:687-94
  10. Bátai I, Kerényi M, Falvai J, Szabó G. Bacterial growth in ropivacaine hydrochloride. Anesth Analg 2002;94:729-31
  11. Kampe S, Poetter C, Buzello S, Wenchel HM, Paul M, Kiencke P, et al. Ropivacaine 0.1% with sufentanil 1 μg/ml inhibits in vitro growth of pseudomonas aeruginosa and does not promote multiplication of staphylococcus aureus. Anesth Analg 2003;97:409-11
  12. Feldman JM, Chapin-Robertson K, Turner J. Do agents used for epidural analgesia have antimicrobial properties? Reg Anesth 1994;19:43-7
  13. Wierda JM, Kleef UW, Lambalk LM, Kloppenburg WD, Agoston S. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth 1991;38:430-5
  14. Atherton DP, Hunter JM. Clinical pharmacokinetics of the newer neuromuscular blocking drugs. Clin Pharmacokinet 1999;36:169-89
  15. Roy JJ, Varin F. Physicochemical properties of neuromuscular blocking agents and their impact on the pharmacokinetic-pharmacodynamic relationship. Br J Anaesth 2004;93:241-8
  16. Wierda JM, Proost JH. Structure-pharmacodynamicpharmacokinetic relatio